GLENMARK GENERICS Trademark

Trademark Overview


On Wednesday, February 20, 2008, a trademark application was filed for GLENMARK GENERICS with the United States Patent and Trademark Office. The USPTO has given the GLENMARK GENERICS trademark a serial number of 77401483. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 21, 2022. This trademark is owned by Glenmark Pharmaceuticals Inc., USA. The GLENMARK GENERICS trademark is filed in the Pharmaceutical Products category with the following description:

Opium alkaloid preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterologi...
glenmark generics

General Information


Serial Number77401483
Word MarkGLENMARK GENERICS
Filing DateWednesday, February 20, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 21, 2022
Registration Number3998466
Registration DateTuesday, July 19, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 27, 2009

Trademark Statements


Goods and ServicesOpium alkaloid preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Preparation for the relief of pain; Preparations for the treatment of asthma
Pseudo MarkGLEN MARK GENERICS
Disclaimer with Predetermined Text"GENERICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 21, 2022
Primary Code005
First Use Anywhere DateTuesday, April 1, 2008
First Use In Commerce DateTuesday, April 1, 2008

Trademark Owner History


Party NameGLENMARK GENERICS INC., USA
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMAHWAH, NJ 07430

Party NameGLENMARK GENERICS INC., USA
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressMAHWAH, NJ 07430

Party NameGlenmark Pharmaceuticals Inc., USA
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMahwah, NJ 07430

Party NameGlenmark Pharmaceuticals Inc., USA
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMahwah, NJ 07430

Trademark Events


Event DateEvent Description
Friday, January 21, 2022CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, July 19, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, September 5, 2017NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Tuesday, September 5, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED
Wednesday, August 23, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, July 14, 2017TEAS SECTION 8 RECEIVED
Tuesday, July 19, 2011REGISTERED-PRINCIPAL REGISTER
Thursday, June 16, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, June 15, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, June 10, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 10, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 9, 2011STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 7, 2011USE AMENDMENT FILED
Thursday, June 9, 2011EXTENSION 4 GRANTED
Thursday, April 21, 2011EXTENSION 4 FILED
Tuesday, June 7, 2011TEAS STATEMENT OF USE RECEIVED
Tuesday, June 7, 2011EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, June 7, 2011PETITION TO REVIVE-GRANTED
Tuesday, June 7, 2011TEAS PETITION TO REVIVE RECEIVED
Monday, May 23, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 23, 2011ABANDONMENT - NO USE STATEMENT FILED
Thursday, October 28, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 27, 2010EXTENSION 3 GRANTED
Thursday, October 21, 2010EXTENSION 3 FILED
Tuesday, October 26, 2010EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, October 26, 2010PETITION TO REVIVE-GRANTED
Tuesday, October 26, 2010TEAS PETITION TO REVIVE RECEIVED
Friday, May 21, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 20, 2010EXTENSION 2 GRANTED
Wednesday, April 21, 2010EXTENSION 2 FILED
Wednesday, May 19, 2010EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, May 19, 2010PETITION TO REVIVE-GRANTED
Wednesday, May 19, 2010TEAS PETITION TO REVIVE RECEIVED
Monday, March 1, 2010EXTENSION 1 GRANTED
Wednesday, October 21, 2009EXTENSION 1 FILED
Wednesday, February 24, 2010PETITION GRANTED - EXTENSION REQUEST FILED
Tuesday, February 2, 2010INCOMPLETE PETITION NOTICE MAILED
Tuesday, February 2, 2010ASSIGNED TO PETITION STAFF
Tuesday, December 1, 2009PETITION TO REVIVE-RECEIVED
Monday, February 1, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 1, 2009EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, December 1, 2009PETITION TO REVIVE-GRANTED
Tuesday, December 1, 2009TEAS PETITION TO REVIVE RECEIVED
Monday, November 23, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 23, 2009ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 21, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 27, 2009PUBLISHED FOR OPPOSITION
Wednesday, January 7, 2009NOTICE OF PUBLICATION
Monday, December 22, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, December 16, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 15, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 15, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 15, 2008ASSIGNED TO LIE
Monday, December 1, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 2, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 2, 2008NON-FINAL ACTION E-MAILED
Monday, June 2, 2008NON-FINAL ACTION WRITTEN
Monday, June 2, 2008ASSIGNED TO EXAMINER
Wednesday, February 27, 2008NOTICE OF PSEUDO MARK MAILED
Tuesday, February 26, 2008NEW APPLICATION ENTERED IN TRAM